Literature DB >> 3220313

Benign oesophageal stricture in Barrett's columnar epithelialised oesophagus and its responsiveness to conservative management.

M Atkinson1, C S Robertson.   

Abstract

The response to treatment of peptic oesophageal stricture associated with columnar lined (Barretts) oesophagus (CLO) has been compared with that in peptic stricture without CLO. Benign oesophageal stricture was present in 23 (41%) of 56 patients consecutive with CLO. In 18 the stricture lay at the squamocolumnar mucosal junction and was associated with reflux oesophagitis, in five it was situated in the columnar lined segment and in four of these it was known to have been preceded by a chronic ulcer at the site of the stricture. Controls were an age and sex matched group of patients with benign stricture related to reflux oesophagitis unassociated with columnar epithelialisation. CLO associated strictures involving squamous mucosa were situated significantly (p less than 0.01) higher in the oesophagus than non-CLO strictures. The response to endoscopic dilatation and active medical treatment was significantly better, as judged by the need for subsequent dilatation (p less than 0.01) in the CLO than in the non-CLO group. It is concluded that associated columnar epithelialisation of the oesophagus is not in itself an indication for antireflux surgery in the management of benign stricture and these usually respond well to dilatation and medical treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3220313      PMCID: PMC1434098          DOI: 10.1136/gut.29.12.1721

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Barrett esophagus: decreased esophageal clearance shown by radionuclide esophageal scintigraphy.

Authors:  K C Karvelis; W E Drane; D A Johnson; E D Silverman
Journal:  Radiology       Date:  1987-01       Impact factor: 11.105

2.  Barrett's oesophagus: pH profile.

Authors:  P Gillen; P Keeling; P J Byrne; T P Hennessy
Journal:  Br J Surg       Date:  1987-09       Impact factor: 6.939

3.  Barrett's esophagus in childhood.

Authors:  E Hassall; W M Weinstein; M E Ament
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

4.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

5.  Esophageal acid sensitivity in Barrett's esophagus.

Authors:  D A Johnson; C Winters; T J Spurling; S J Chobanian; E L Cattau
Journal:  J Clin Gastroenterol       Date:  1987-02       Impact factor: 3.062

6.  Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux.

Authors:  B B Dahms; F C Rothstein
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

7.  Barrett's esophagus: clinical, endoscopic, and histologic spectrum in fifty patients.

Authors:  P Kerlin; G d'Mellow; A van Deth
Journal:  Aust N Z J Med       Date:  1986-04

8.  Barrett's oesophagus: a clinical study of 52 patients.

Authors:  B T Cooper; G O Barbezat
Journal:  Q J Med       Date:  1987-02

9.  The columnar-lined esophagus--analysis of 26 cases.

Authors:  A H Robbins; J A Hermos; E M Schimmel; D M Friedlander; R A Messian
Journal:  Radiology       Date:  1977-04       Impact factor: 11.105

10.  Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.

Authors:  M G Sarr; S R Hamilton; G C Marrone; J L Cameron
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

View more
  2 in total

1.  Benign oesophageal stricture in Barrett's oesophagus.

Authors:  B T Cooper
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

2.  Multicenter prospective evaluation of laparoscopic antireflux surgery. Preliminary report.

Authors:  A Cuschieri; J Hunter; B Wolfe; L L Swanstrom; W Hutson
Journal:  Surg Endosc       Date:  1993 Nov-Dec       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.